Pallas vs Hims & Hers: GLP-1 Telehealth Compared

Hims & Hers is one of the largest telehealth brands in the US, and its Weight Loss by Hims program became one of the most-searched GLP-1 telehealth options after launching in 2024. Pallas Health is a newer alternative focused specifically on GLP-1 weight-loss care. Both can put a GLP-1 in your hands — but as of 2026 the two have diverged in ways that matter, especially around compounded medications, membership fees, and how much you can manage yourself. Here's what's actually different.

Pricing on both sides changes often; figures below reflect each platform's published pricing as of August 2026. Confirm current numbers on both sites before signing up.

The three differences that matter most in 2026

1. Pallas offers FDA-approved brands and clinician-personalized compounded — Hims is now branded-only. Following its March 2026 Novo Nordisk settlement, Hims's weight-loss lineup is FDA-approved brands only (Wegovy®, Zepbound®, Ozempic®, Mounjaro®, and the Foundayo™ pill). Pallas dispenses the FDA-approved brands too and, when a clinician decides a brand isn't the right fit, a per-patient compounded preparation. Compounding isn't a downgrade — it's personalization a fixed-dose pen can't do: a titration step the brand doesn't manufacture, or a formulation adjusted for the individual patient when a clinician judges it appropriate. A branded-only platform can't offer that at all.
2. Hims requires a separate membership; Pallas pricing is all-in. Hims's published prices are for medication only, and its site states that an active Weight Loss Membership — $39 for the first month, auto-renewing at $149/month — is required, billed separately, and that medication is not available without it. With Pallas there is no membership or platform fee: one plan price includes the provider, ongoing check-ins, dose adjustments, unlimited messaging, and shipping, and it doesn't rise as your dose titrates up. The Pallas companion app (iOS and Android) is free, with no subscription.
3. Care is 100% online and usually asynchronous. In most states there's no scheduled video visit to book — you complete everything online, and you can message your provider directly through the portal anytime, day or night, about side effects, dose questions, or refills. The same portal lets you track orders, request refills, switch plans, manage billing, and cancel — all yourself.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

What Hims does well

Scale and brand recognition. Hims & Hers is a public company (NYSE: HIMS) with millions of customers across its telehealth stack. The brand is familiar, the app and billing infrastructure are polished, and the support team is large.

Cross-vertical convenience. If you're already on Hims for hair loss, ED, testosterone, or mental health, adding weight loss into the same app is genuinely easy — one login, one billing relationship. Pallas does none of those things; it's GLP-1 weight care only.

Branded sticker prices. Through its manufacturer partnerships, Hims's branded medication prices are genuinely low — as of August 2026, injectable Wegovy® from $199/month, the Wegovy® pill from $149/month, and Zepbound® from $299/month (these are starting-dose "from" prices; higher doses cost more, and the $149/month membership is billed on top). Pallas's brand-name medications are cash-pay at list-style pricing, which runs well above Hims's partnership pricing per dose. If your heart is set on a specific FDA-approved brand at the lowest sticker price, compare the brand numbers directly — Hims will usually win that line item. We'll say that plainly.

A larger content and app ecosystem. Hims has extensive educational content, tracking, and community features. If you want a product-experience-heavy platform, that's real.

What Pallas does differently

Both tiers, with compounding as personalization — not a knockoff. This is the headline. Hims exited compounding; Pallas keeps both pathways. You can get FDA-approved Wegovy®, Ozempic®, Zepbound®, and Mounjaro®, and — when a clinician decides a brand isn't the right fit — compounded semaglutide or compounded tirzepatide weekly injections. The reason a clinician reaches for compounded isn't price; it's fit: a titration step the brand doesn't manufacture, or a per-patient formulation when a clinician judges it appropriate. A fixed-dose branded pen can't be tailored that way, and a branded-only competitor can't offer it at all.

No membership fee, one all-in number. Compounded plans through Pallas are one price with everything included: semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. The price covers your provider, check-ins, dose adjustments, unlimited messaging, and shipping — there is no separate membership line, and the price does not increase as your dose titrates up. At Hims, whichever medication you choose, remember to add the $149/month membership to the medication price when you compare totals.

Single-category focus. Pallas isn't a men's-health company that added GLP-1 — it's GLP-1-first. For patients who want to be a priority rather than one of a dozen verticals, that focus shows up in provider responsiveness and program design.

A free companion app. The Pallas companion app (Protein & GLP-1 Tracker, on iOS and Android) tracks protein, steps, weight trend, and dose reminders — free, with no subscription, useful whether or not you're a prescription patient.

Everything self-serve in a 100%-online portal. In most states, care is fully asynchronous — no video visit to schedule. Check order status and shipment tracking, request refills, switch plans, update billing, and cancel anytime, all yourself with no phone queue. Best of all, you can message your provider directly through the portal anytime, day or night, about side effects, dose adjustments, or refills, and they respond — typically within a business day.

Pricing: the real comparison

The honest answer depends on which medication you want.

If you want a compounded GLP-1

Pallas offers one; Hims no longer does. Pallas's compounded plans are all-in:

• Semaglutide injection: $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Provider care, dose changes, messaging, and shipping are all included, and the price is the same at every dose.
• Tirzepatide injection: $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. Same all-in structure.

If a compounded preparation is what your clinician recommends, Pallas is the option that still has it.

If you want an FDA-approved brand

Both platforms can prescribe brand-name, and here Hims usually wins on price: its partnership prices (Wegovy® from $199/month injectable or $149/month for the pill, Zepbound® from $299/month, as of August 2026) are well below Pallas's cash-pay brand pricing. Two things to keep in your math, though: those are starting-dose "from" prices that rise at higher doses, and the $149/month membership is required and billed separately on top of every medication price. Pallas's advantage on the branded side isn't sticker price — it's the absence of a membership line and a fully self-serve portal.

The honest summary: Pallas wins on still offering compounded, on no membership fee, on flat pricing that doesn't rise with your dose, and on all-in transparency. Hims wins on scale, cross-vertical convenience, and branded per-dose sticker price.

The hidden cost: friction

Across either platform, the most underrated cost is the time you lose to friction — delayed shipments, slow responses, surprise line items. Pallas optimizes hard for response time as a smaller, single-category company; Hims has more total support capacity but slower per-ticket resolution at its volume. Being able to check your own order status and message your provider directly in the portal removes a lot of that friction up front.

Product experience differences

Managing your care

The Pallas portal is built for self-service, and care is 100% online — asynchronous in most states, so there's no video visit to schedule. Order status and tracking, refill requests, plan switches, billing updates, and self-serve cancellation all happen there, no phone calls. The piece patients value most is direct provider messaging: send a note anytime, day or night, about a side effect, a dose question, or a refill, and your provider replies — usually within a business day. Hims offers account management and messaging inside its broader app; the difference is how much Pallas pushes toward doing everything yourself in one place.

Provider experience

Hims works with a large W-2 and contract provider network; at that scale you're unlikely to see the same provider on repeat visits, which is fine for routine dose management. Pallas works with a smaller provider group, and patients often build a longer relationship with the same provider — useful when managing comorbidities or titration issues.

Intake and qualification

Both use a standard online intake (about 5–10 minutes) followed by provider review, with decisions typically within a business day. Hims's intake ties into its broader app so you can later add other verticals; Pallas's is focused exclusively on GLP-1 weight management.

Pharmacy and shipping

Both use US-licensed pharmacies and ship in discreet packaging; timelines are similar (2–5 business days) and depend on routing and your state.

Who should pick which

Hims is probably the better fit if:

• You want a specific FDA-approved brand at the lowest per-dose sticker price and don't mind the $149/month membership on top
• You're already a Hims customer for hair, ED, testosterone, or mental health
• You want a polished, app-driven experience with tracking and community features
• Brand familiarity and scale reassure you

Pallas is probably the better fit if:

• You want a clinician's full toolkit — FDA-approved brands and the option of a personalized compounded preparation when a brand's fixed doses or formulation aren't the right fit (Hims no longer offers compounded)
• You don't want a separate membership or platform fee on top of medication
• You prefer one flat, all-in price that stays the same as your dose changes
• You want care that's 100% online and asynchronous, with the ability to message your provider directly anytime about symptoms or refills
• You want to manage everything yourself — orders, refills, plan switches, billing — in one portal
• You'd use a free companion app (iOS and Android) to track protein, steps, and your weight trend

Either works well if:

• You want an FDA-approved brand and have compared the all-in numbers both ways (Hims's medication price + membership vs Pallas's cash-pay brand price)

Switching between platforms

Both support clean transitions. Export your prescription history from your current platform's portal, complete the new intake noting your current medication and dose, and a provider continues or adjusts it. No restart of titration is needed if you haven't been off medication for more than four weeks. For the clinical side of switching molecules, see semaglutide vs tirzepatide; for what the first 90 days feel like, see our first 3 months guide.

References

Platform pricing and program details reflect each company's publicly published terms as of August 2026 and change frequently — confirm current numbers on each platform's site before enrolling. The regulatory basis for compounded preparations is summarized by the FDA.

1. Hims & Hers. Weight Loss by Hims — program and medication pricing, as published August 2026 (membership: $39 first month, auto-renews at $149/month, billed separately from medication).
2. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.

Bottom line: Hims is the bigger brand with a broad product suite, a polished app, and low branded sticker prices through manufacturer partnerships — plus a required $149/month membership billed on top of every medication. Pallas is GLP-1-focused, charges no membership fee, and gives a clinician the full toolkit — FDA-approved brands plus a personalized compounded preparation when a brand's fixed doses or formulation aren't the right fit. Compounded pricing is one all-in number that stays flat at every dose, care is 100% online and async with anytime provider messaging, and you run everything — orders, refills, plan changes, billing — from one self-serve portal, plus a free companion app on iOS and Android. If you want fee-free all-in simplicity or a clinician who can personalize beyond a fixed-dose pen, Pallas fits; if you want the lowest branded sticker inside a larger ecosystem, Hims fits.